Collegium contributes to independent education by supporting Continuing Medical Education (CME) and Non-CME Educational Grants.
Grant proposals should be submitted to Collegium through our online portal. The portal will also allow you to track the progress of your existing submission, and report on any of your approved grants.
Requests for support should be submitted no less than 60 days prior to the start date to ensure enough lead-time for review and processing of requests.
Areas of interest include, but are not limited to:
- Advancing healthcare practitioner understanding of the pharmacologic and non-pharmacologic management of pain, including differences in opioid molecules and formulations
- Improving patient awareness of options for pharmacologic and non-pharmacologic management of pain, including differences in opioid molecules and formulations
- Increasing awareness and understanding around abuse, misuse, and diversion of prescription opioids and best practices for their mitigation
- Improving understanding of the impact of local, state, and federal policy on the management of people with pain
Collegium is required, as part of the FDA approvals for its products, to participate in the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS). As Collegium is a member of the REMS Program Companies (RPCs), any grant request for Continuing Medical Education (CME) programs that complies with REMS, should be submitted directly through the program’s application process. Additional information can be found on the REMS website, here.
For additional information on Collegium’s Educational Grant Program, please contact us at: EducationalGrantReviewCommittee@collegiumpharma.com.
If you have any questions about creating an account or any other technical support questions about the portal, please call +1 (718) 576-1406 or click here.